Home/Filings/3/0000899243-21-004985
3//SEC Filing

PureTech Health LLC 3

Accession 0000899243-21-004985

CIK 0001817229other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 9:52 PM ET

Size

6.5 KB

Accession

0000899243-21-004985

Insider Transaction Report

Form 3
Period: 2021-02-04
Holdings
  • Series A-1 Preferred Stock

    Common Stock (1,470,588 underlying)
  • Series A-2 Preferred Stock

    Common Stock (1,595,210 underlying)
  • Series B Preferred Stock

    Common Stock (141,402 underlying)
Footnotes (1)
  • [F1]Each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a 13.6-for-one basis, has no expiration date and will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727395

Filing Metadata

Form type
3
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 9:52 PM ET
Size
6.5 KB